Year : 2009 | Volume
: 2 | Issue : 1 | Page : 19--22
Using continuous renal replacement therapy to manage patients of shock and acute renal failure
Sachin S Soni, Amit P Nagarik, Gopal Kishan Adikey, Anuradha Raman
Department of Nephrology, Mediciti Hospitals, Hyderabad, Andhra Pradesh, India
Department of Nephrology, Mediciti Hospitals, Hyderabad, Andhra Pradesh
Background: The incidence of acute renal failure (ARF) in the hospital setting is increasing. It portends excessive morbidity and mortality and a considerable burden on hospital resources. Extracorporeal therapies show promise in the management of patients with shock and ARF. It is said that the potential of such therapy goes beyond just providing renal support. The aim of our study was to analyze the clinical setting and outcomes of critically ill ARF patients managed with continuous renal replacement therapy (CRRT). Patients and Methods: Ours was a retrospective study of 50 patients treated between January 2004 and November 2005. These 50 patients were in clinical shock and had concomitant ARF. All of these patients underwent CVVHDF (continuous veno-venous hemodiafiltration) in the intensive care unit. For the purpose of this study, shock was defined as systolic BP < 100 mm Hg in spite of administration of one or more inotropic agents. SOFA (Sequential Organ Failure Assessment) score before initiation of dialysis support was recorded in all cases. CVVHDF was performed using the Diapact® (Braun) CRRT machine. The vascular access used was as follows: femoral in 32, internal jugular in 8, arteriovenous fistula (AVF) in 4, and subclavian in 6 patients. We used 0.9% or 0.45% (half-normal) saline as a prefilter replacement, with addition of 10% calcium gluconate, magnesium sulphate, sodium bicarbonate, and potassium chloride in separate units, while maintaining careful monitoring of electrolytes. Anticoagulation of the extracorporeal circuit was achieved with systemic heparin in 26 patients; frequent saline flushes were used in the other 24 patients. Results: Of the 50 patients studied, 29 were males and 21 females (1.4:1). The average age was 52.88 years (range: 20-75 years). Causes of ARF included sepsis in 24 (48%), hemodynamically mediated renal failure (HMRF) in 18 (36%), and acute over chronic kidney disease in 8 (16%) patients. The overall mortality was 74%. The average SOFA score was 14.31. The variables influencing mortality on multivariate analysis were: age [odds ratio (OR):1.65; 95% CI: 1.35 to 1.92; P = 0.04], serum creatinine (OR:1.68; 95% CI: 1.44 to 1.86; P = 0.03), and serum bicarbonate (OR: 0.76; 95% CI: 0.55 to 0.94; P = 0.01). On univariate analysis the SOFA score was found to be a useful predictor of mortality. Conclusions: Despite advances in treating critically ill patients with newer extracorporeal therapies, mortality is dismally high. Multiorgan dysfunction adversely affects outcome of CRRT. Older age, level of azotemia, and severity of metabolic acidosis are important predictors of adverse outcome.
|How to cite this article:|
Soni SS, Nagarik AP, Adikey GK, Raman A. Using continuous renal replacement therapy to manage patients of shock and acute renal failure.J Emerg Trauma Shock 2009;2:19-22
|How to cite this URL:|
Soni SS, Nagarik AP, Adikey GK, Raman A. Using continuous renal replacement therapy to manage patients of shock and acute renal failure. J Emerg Trauma Shock [serial online] 2009 [cited 2020 Jul 2 ];2:19-22
Available from: http://www.onlinejets.org/text.asp?2009/2/1/19/44678
Continuous renal replacement therapy (CRRT) has emerged as the dialysis technique of choice for patients of shock with acute renal failure (ARF).  It is being increasingly utilized in hemodynamically unstable patients. Whether it is superior to intermittent hemodialysis is still a debatable issue. , As this therapy is expensive, widespread usage in developing countries like India is not feasible. We report our 2-year experience of treating 50 critically ill cases with CRRT.
Patients and Methods
All critically ill patients undergoing CRRT between January 2004 and December 2006 were retrospectively analyzed. CRRT was advised in critically ill patients with shock and ARF. Shock was defined as systolic BP ® CRRT (B. Braun Company).
We used the Diacap Acute (B. Braun) polysulfone filter (effective surface area: 1.2 m 2 and ultrafiltration coefficient: 42 ml/h/mm Hg). Vascular access included arteriovenous fistula (AVF) or double-lumen 12-French catheter (DLC) inserted into the internal jugular, subclavian, or femoral veins. Hemodiafiltration was accomplished using a blood flow rate of 100-150 ml/min. Commercially available dextrose and potassium-free Hemosol BO (Hospal Division, Gambro Limited) was used as a dialysis solution at a fixed flow rate of 1200 ml/h. A fixed amount of replacement fluid of 400 ml/h by predilution method comprising 0.9% or 0.45% (half-normal) saline was used. Addition of 10% calcium gluconate, magnesium sulphate, 7.5% sodium bicarbonate, and potassium chloride was done, with monitoring of the levels of these electrolytes. Proctoclysis enema (sodium phosphate 10%) given through a nasogastric tube was used for phosphorous replacement as injectable phosphorous replacement solution was unavailable. The ultrafiltration (UF) rate was based on the volume status of the patient as assessed by central venous pressure (CVP) monitoring. Clearance rate per hour was calculated by addition of dialysis solution flow rate and UF rate (clearance rate/hour = 1200 + UF rate/h).
Anticoagulation of the extracorporeal circuit was achieved with systemic heparin, with a target partial thromboplastin time of 65 s in the arterial (prefilter) line. No anticoagulation was used in patients having systemic coagulopathy. SOFA (Sequential Organ Failure Assessment) score  before initiation of CRRT was recorded in all cases. ARF was defined as a rise of serum creatinine by 25% over baseline in patients without preexisting renal disease. Acute over chronic kidney disease (CKD) was defined as uncharacteristic change in renal function (increase in serum creatinine by 1 mg/dl or 25% over baseline) developing over days in patients having deranged creatinine (>2 mg/dl) for more than 3 months. Hemodynamically mediated renal failure (HMRF) was defined as ARF developing secondary to shock. Survival or mortality was the main outcome measure of this analysis.
All data was systematically collected and tabulated. All values were expressed as a mean ± standard deviation. Student's t-test was used for analysis of parametric variables and the Mann-Whitney test for nonparametric variables. Mortality was the main outcome measure. Multivariable logistic regression analysis was then conducted to assess the factors influencing mortality. Based on the results of the univariate analysis, the covariates considered were age, male gender, SOFA score, and serum creatinine and serum bicarbonate at CRRT initiation. The SPSS for Windows (Student Version) was used for the statistical analysis. A P value of injury (AKI), occurs as a result of ischemic and toxic kidney injury and is a life-threatening complication of sepsis and other syndromes in the intensive care unit (ICU).  ARF is an independent predictor of mortality in critically ill cases.  The use of continuous therapies was first described three decades ago by Kramer et al .  In comparison with the Western world, where CRRT is used in 80% of ICU ARF,  its use is limited in India. Possible reasons include high cost, technical difficulties, and shortage of adequately trained staff. Most of the patients in our study were elderly, as has also been reported by Turney et al.  and Mehta et al .  Sepsis was the most common cause of ARF in our study. A large multinational, multicenter study has identified septic shock as the etiology of ARF in 47.5% cases, which is consistent with our observation. 
The mean duration of CRRT was 37.51 ± 19.37 h. Many factors, including clotting of filter, conversion of patients to intermittent hemodialysis after achieving hemodynamic stability, and death of the patients during the therapy determined the duration of treatment. The prohibitive cost did not allow us to replace the filter on a daily basis as has been recommended by some authors.  We achieved a mean clearance rate of 1650 ml/h. Taking the average weight of Indian adults to be around 50-60 kg, we achieved a clearance of around 27-33 ml/kg/h. A similar clearance rate has been reported by a large multicenter trial.  The clearance achieved in our study is lower than the target clearance of 35 ml/kg/h reported from most Western centers  ; this is because we avoided weight-based alteration in clearance values and instead followed a fixed prescription protocol to make the procedure less complicated and more user friendly.
The overall mortality in our study was 74%. Many other studies have reported high mortality in critically ill ARF [Table 6]. In our study, older age, azotemia, and metabolic acidosis were predictors of adverse outcome, similar to observations by other authors. ,, Many studies have tried to address the question of the superiority of one therapy over the other (CRRT vs Intermittent hemodialysis) but the results are equivocal. A recently published meta-analysis by Tonelli et al. has shown both modalities to be equally effective. (20)
Limitations of the study
This study is on critically ill patients of shock and ARF treated with CRRT without the use of any newer intervention. Absence of a control group randomized to either intermittent hemodialysis (IHD) or high-volume peritoneal dialysis is a major limitation of this study. We were also not able to deliver the optimum CRRT dose of 35 ml/kg/h for logistic reasons.
Technological advances in the treatment of critically ill renal failure patients are yet to translate into survival benefits. Multiorgan dysfunction adversely affects the outcome of CRRT. Older age, level of azotemia, and severity of metabolic acidosis are important predictors of adverse outcome. Septic shock is the commonest cause of ARF in critically ill patients and is associated with high mortality. In India, the application of the CRRT technique is largely limited to private-sector corporate hospitals. The prohibitive cost and lack of trained staff are the major factors limiting its wider use.
|1||Clark WR, Murphy MH, Alaka KJ, Mueller BA, Pastan SO, Macias WL. Urea kinetics during continuous hemofiltration. ASAIO J 1992;38:M664-7. |
|2||Ronco C, Bellomo R. Dialysis in intensive care unit patients with acute kidney injury: Continuous therapy is superior. Clin J Am Soc Nephrol 2007;2:597-600.|
|3||Himmelfarb J. Continuous renal replacement therapy in the treatment of acute renal failure: Critical assessment is required. Clin J Am Soc Nephrol 2007;2:385-9.|
|4||Vincent JL, Moreno R, Takala J, Willatts S, De Mendonηa A, Bruining H, et al . The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med 1996;22:707-10.|
|5||Schrier RW, Wang W, Poole B, Mitra A. Acute renal failure: Definitions, diagnosis, pathogenesis and therapy. J Clin Invest 2004;114:5-14.|
|6||Manns M, Sigler MH, Teehan BP. Continuous renal replacement therapies: An update. Am J Kidney Dis 1998;32:185-207.|
|7||Kramer P, Wigger W, Rieger J, Matthaei D, Scheler F. Arteriovenous haemofiltration: A new and simple method for treatment of over-hydrated patients resistant to diuretics [in German]. Klin Wochenschr 1977;55:1121-2.|
|8||Uchino S, Kellum JA, Bellomo R, Doig GS, Morimatsu H, Morgera S, et al . Acute renal failure in critically ill patients: A multinational, multicenter study. JAMA 2005;294:813-8.|
|9||Turney JH, Marshall DH, Brownjohn AM, Ellis CM, Parsons FM. The evaluation of acute renal failure, 1956-1988. Q J Med 1990;74:83-104. |
|10||Mehta RL, Pascual MT, Soroko S, Savage BR, Himmelfarb J, Ikizler TA, et al . Spectrum of acute renal failure in the intensive care unit: The PICARD experience. Kidney Int 2004;66:1613-21.|
|11||Prakash J, Murthy AS, Vohra R, Rajak M, Mathur SK. Acute renal failure in the intensive care unit. J Assoc Physics India 2006;54:784-8.|
|12||Ronco C, Bellomo R, Homel P, Brendolan A, Dan M, Piccinni P, et al . Effect of different doses in CVVH on outcomes of acute renal failure: A prospective randomized trial. Lancet 2000;356:26-30.|
|13||Vinsonneau C, Camus C, Combes A, Costa de Beauregard MA, Klouche K, Boulain T, et al . Continuous venovenous haemodiafiltration versus intermittent haemodialysis for acute renal failure in patients with multiple-organ dysfunction syndrome: A multicentre randomised trial. Lancet 2006;368:379-85.|
|14||Mehta RL, McDonald B, Gabbai FB, Pahl M, Pascual MT, Farkas A, et al . A randomized clinical trial of continuous versus intermittent dialysis for acute renal failure. Kidney Int 2001;60:1154-63.|
|15||Lobo V, Joshi A, Joseph S, Wandre S, Norton C, Joshi S, et al . Continuous veno-venous hemofiltration for ARF in critically ill patients. Indian J Crit Care Med 2004;8:148-52.|
|16||Guerin C, Girard R, Sellit JM, Ayzac L. Intermittent versus continuous renal replacement therapy for acute renal failure in intensive care units: Results from a multicenter prospective epidemiological survey. Intensive Care Med 2002;28:1411-8. |
|17||Uehlinger DE, Jakob SM, Ferrari P, Eichelberger M, Huynh-Do U, Marti HP, et al . Comparison of continuous and intermittent renal replacement therapy for acute renal failure. Nephrol Dial Transplant 2005;20:1630-7.|
|18||EI-Shahawy MA, Agbing LU, Badillo E. Severity of illness scores and the outcome of acute tubular necrosis. Int Urol Nephrol 2000;32:185-91.|
|19||Kohli HS, Bhat A, Jairam A, Aravindan AN, Sud K, Jha V, et al . Predictors of mortality in acute renal failure in a developing country: A prospective study. Ren Fail 2007;29:463-9.|
|20||Tonelli M, Manns B, Feller-Kopman D. Acute renal failure in the intensive care unit: A systematic review of the impact of dialytic modality on mortality and renal recovery. Am J Kidney Dis 2002;40:875-85.|